Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)

Glaxo is now starting to promote Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS).

This will be big.

Approx 30 million Americans have irritable bowel syndrome...it's three times more common in women than in men.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote